首页 > 市场调查报告书 > 製药

基因治疗学和RNAi

市场调查报告书

商品编码

1489179

全球 mRNA 治疗市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global mRNA Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年05月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球 mRNA 治疗市场需求预计将从 2023 年的 122.3 亿美元达到近 498.2 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 16.89%。

mRNA 疗法是一类利用信使 RNA (mRNA) 分子来引导细胞在体内产生治疗性蛋白质或抗原的药物。这些基于 mRNA 的药物透过利用人体的天然蛋白质合成机制产生特定的治疗分子，提供了一种治疗疾病的新方法。这些药物有望广泛应用，包括疫苗、癌症免疫疗法、蛋白质替代疗法和再生医学。

市场动态

人们对基于 mRNA 的药物开发的兴趣和投资不断增长，推动了 mRNA 治疗市场的发展。 mRNA 技术的多功能性和潜力可满足未满足的医疗需求，包括传染病、癌症、遗传性疾病和罕见疾病，推动了市场的成长。 mRNA 疗法透过利用人体的天然蛋白质合成机制在细胞内产生治疗性蛋白质或抗原，提供了一种新的药物开发方法，实现有针对性和可客製化的治疗策略。此外，mRNA 递送系统、脂质奈米颗粒配方和 mRNA 稳定技术的进步提高了治疗功效、生物利用度和安全性，推动了市场采用。

此外，基于 mRNA 的 COVID-19 疫苗的快速开发和监管批准证明了 mRNA 技术用于疫苗开发的可行性和可扩展性，从而加速了对其他疾病的 mRNA 疗法的投资和研究。此外，製药公司、生物技术公司、学术研究机构和政府机构之间的合作推动了 mRNA 药物发现的创新和管道开发，进一步刺激了市场成长。然而，监管障碍、製造复杂性以及公众对基因疗法的看法担忧可能会挑战未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球 mRNA 治疗市场的各个细分市场进行了包容性评估。 mRNA 治疗产业的成长和趋势为本研究提供了整体方法。

市场区隔

mRNA 治疗市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按申请

传染性疾病
肿瘤学
罕见遗传疾病
呼吸疾病
其他的

按类型

预防性
治疗性

按最终用途

医院和诊所
研究机构
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲 mRNA 治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。 mRNA治疗市场的主要参与者包括Moderna Inc.、BioNTech SE、CureVac NV、Arcturus Therapeutics、赛诺菲、葛兰素史克公司、Argos Therapeutics Inc.、Ethris、辉瑞公司、阿斯特捷利康。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：mRNA 治疗公司的竞争格局

mRNA治疗市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
Moderna Inc.

公司简介
公司收入
产品
最近的发展

BioNTech SE

公司简介
公司收入
产品
最近的发展

CureVac NV

公司简介
公司收入
产品
最近的发展

Arcturus Therapeutics

公司简介
公司收入
产品
最近的发展

Sanofi

公司简介
公司收入
产品
最近的发展

GSK Plc.

公司简介
公司收入
产品
最近的发展

Argos Therapeutics Inc.

公司简介
公司收入
产品
最近的发展

Ethris

公司简介
公司收入
产品
最近的发展

Pfizer Inc.

公司简介
公司收入
产品
最近的发展

AstraZeneca

公司简介
公司收入
产品
最近的发展

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR112114584

The global demand for mRNA Therapeutics Market is presumed to reach the market size of nearly USD 49.82 Billion by 2032 from USD 12.23 Billion in 2023 with a CAGR of 16.89% under the study period 2024-2032.

mRNA therapeutics is a class of drugs that utilize messenger RNA (mRNA) molecules to instruct cells to produce therapeutic proteins or antigens within the body. These mRNA-based drugs offer a novel approach to treating diseases by harnessing the body's natural protein synthesis machinery to produce specific therapeutic molecules. These drugs hold promise for a wide range of applications, including vaccines, cancer immunotherapy, protein replacement therapy, and regenerative medicine.

MARKET DYNAMICS

The growing interest and investment in mRNA-based drug development drives the market for mRNA therapeutics. The versatility and potential of mRNA technology to address unmet medical needs, including infectious diseases, cancer, genetic disorders, and rare diseases, fuel market growth. mRNA therapeutics offer a novel approach to drug development by harnessing the body's natural protein synthesis machinery to produce therapeutic proteins or antigens within cells, enabling targeted and customizable treatment strategies. Moreover, advancements in mRNA delivery systems, lipid nanoparticle formulations, and mRNA stabilization techniques enhance therapeutic efficacy, bioavailability, and safety profiles, driving market adoption.

Additionally, the rapid development and regulatory approval of mRNA-based COVID-19 vaccines demonstrate the feasibility and scalability of mRNA technology for vaccine development, accelerating investment and research in mRNA therapeutics for other diseases. Furthermore, collaborations between pharmaceutical companies, biotechnology firms, academic research institutions, and government agencies propel innovation & pipeline development in mRNA drug discovery, further stimulating market growth. However, regulatory hurdles, manufacturing complexities, and public perception concerns regarding genetic therapies may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of mRNA Therapeutics. The growth and trends of mRNA Therapeutics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the mRNA Therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

Infectious Diseases
Oncology
Rare Genetic Diseases
Respiratory Diseases
Others

By Type

Prophylactic
Therapeutic

By End-use

Hospitals & Clinics
Research Organizations
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the mRNA Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the mRNA Therapeutics market include Moderna Inc., BioNTech SE, CureVac N.V., Arcturus Therapeutics, Sanofi, GSK Plc., Argos Therapeutics Inc., Ethris, Pfizer Inc., AstraZeneca. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. MRNA THERAPEUTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Application
- 3.7.2 Market Attractiveness Analysis By Type
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL MRNA THERAPEUTICS MARKET ANALYSIS BY APPLICATION

5.1. Overview By Application
5.2. Historical and Forecast Data
5.3. Analysis By Application
5.4. Infectious Diseases Historic and Forecast Sales By Regions
5.5. Oncology Historic and Forecast Sales By Regions
5.6. Rare Genetic Diseases Historic and Forecast Sales By Regions
5.7. Respiratory Diseases Historic and Forecast Sales By Regions
5.8. Others Historic and Forecast Sales By Regions

6. GLOBAL MRNA THERAPEUTICS MARKET ANALYSIS BY TYPE

6.1. Overview By Type
6.2. Historical and Forecast Data
6.3. Analysis By Type
6.4. Prophylactic Historic and Forecast Sales By Regions
6.5. Therapeutic Historic and Forecast Sales By Regions

7. GLOBAL MRNA THERAPEUTICS MARKET ANALYSIS BY END-USE

7.1. Overview By End-use
7.2. Historical and Forecast Data
7.3. Analysis By End-use
7.4. Hospitals & Clinics Historic and Forecast Sales By Regions
7.5. Research Organizations Historic and Forecast Sales By Regions
7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL MRNA THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE MRNA THERAPEUTICS COMPANIES

9.1. MRNA Therapeutics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF MRNA THERAPEUTICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Moderna Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. BioNTech SE
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. CureVac N.V.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Arcturus Therapeutics
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Sanofi
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. GSK Plc.
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Argos Therapeutics Inc.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Ethris
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Pfizer Inc.
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. AstraZeneca
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments